Isla D, Massuti B, Lázaro M, Ruiz de Alda L, Gordo R, Ortega-Joaquín N, Oyagüez I
Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib
Lung Cancer Management 2020. doi.org/10.2217/lmt-2019-0011
de Andrés-Nogales F, Casado MÁ, Trillo JL, Ruiz-Moreno JM, Martínez-Sesmero JM, Peralta G, Poveda JL, Ortiz P, Ignacio E, Zarranz-Ventura J, Udaondo P, Mur C, Álvarez E, Cervera E, Martínez M, Llorente I, Zulueta J, Rodríguez-Maqueda M, García-Layana A, Martínez-Olmos J
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema: The MULTIDEX-EMD Study
Pharmacoecon Open. 2020;4(4):615-624
Soto J, Casado MA
La trayectoria metodológica de la evaluación de la eficiencia y su futuro
Papeles de Economía Española 2019; 160: 156-164
Oyagüez I, Suárez C, López-Sendón JL, González-Juanatey JR, de Andrés-Nogales F, Suarez J, Polanco C, Soto J
Cost-effectiveness analysis of apixaban versus edoxaban in atrial fibrillation patients for stroke prevention
Pharmacoecon Open. 2020;4(3):485-497
Presa M, Pérez-Ruiz F, Oyagüez I
2nd line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients
Clin. Rheumatol 2019. doi: 10.1007/s10067-019-04739-3
Capel M, Ciudin A, Mareque M, Rodríguez-Rincón RM, Simón S, Oyagüez I
Cost-effectiveness analysis of exenatide versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus
PharmacoEconomics – Open 2020; 4, 277–286
Puig L, Fernández-Freire LR, Burgos-Pol R, Gomez I, Peral C, Gomez S, Rebollo Laserna FJ
Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
Dermatol Ther (Heidelb). doi: 10.1007/s13555-019-0301-6
Marron SE, Tomas-Aragones L, Moncin-Torres CA, Gomez-Barrera M, Alcalde-Herrero VM, Garcia-Latasa de Aranibar FJ
Adult Patients with Atopic Dermatitis Treated with Dupilumab in Routine Clinical Practice: Preliminary Data at Week 16
Neuropsychiatry 2019; 9(1):749–755
Podzamczer D, Rozas N, Domingo P, Miralles C, den Eynde EV, Romero A, Deig E, Knobel H, Pasquau J, Antela A, Clotet B, Geijo P, de Castro ER, Casado MA, Muñoz A, Casado A
Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to CART. PRO-STR Study
Current HIV Research 2018, 16, 425-435
Herrera-Usagre M, Santana V, Burgos-Pol R, Oliva JP, Sabater E, Rita-Acosta M, Casado MA, Cruces S, Pacheco M, Solorzano Perez C